The Director-General of Health says she expects puberty blocker prescriptions to continue to fall. 

The Ministry of Health has released an evidence brief showing a lack of quality evidence backing their effectiveness and safety for gender dysphoria.

It says they should be prescribed by a clinician experienced in gender-affirming care, in a team offering wide support.

Dr Diana Sarfati says use was already declining. 

"The peak prescription for puberty blockers was around 2021- and in the last couple of years, we're already starting to see a drop-off."

LISTEN ABOVE

The Director-General of Health says she expects puberty blocker prescriptions to continue to fall.&nbsp;
The Ministry of Health has released an evidence brief showing a lack of quality evidence backing their effectiveness and safety for gender dysphoria.
It says they should be prescribed by a clinician experienced in gender-affirming care, in a team offering wide support.
Dr Diana Sarfati says use was already declining.&nbsp;
"The peak prescription for puberty blockers was around 2021- and in the last couple of years, we're already starting to see a drop-off."
LISTEN ABOVE

With a straight down the middle approach, Heather du Plessis-Allan Drive on Newstalk ZB delivers the very latest news and views to New Zealanders as they wrap up their day.

Heather du Plessis-Allan Drive

Dr Diana Sarfati: Director-General of Health on the Ministry of Health brief examining the benefits and risks of puberty blockers

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/41280a7c-a2e6-49a7-8fa4-b22f004bf139/transcript

Advertisement